Ghana is scheduled to begin the production of COVID-19 vaccines locally.
Speaking during his 26th address to the nation on measures taken against the spread of COVID-19 in the country, the President of Ghana Nana Addo-Dankwa Akufo-Addo indicated that the country will establish a National Vaccine Institute .
According to the President, the National Vaccine Institute to be established by the country is to spearhead this development of COVID-19 vaccines locally.
He further added that the Government of Ghana under his leadership will invest an amount of twenty five million United States dollars (US$25 million) this year into the development of COVID-19 vaccines locally under the National Vaccine Institute.
A portion of President Nana Addo-Dankwa Akufo-Addo’s statement said ;
“The global shortage of vaccines means that we must develop our capacity to produce our own vaccines domestically, and reduce our dependence on foreign supplies. We must be self-sufficient in this regard in the future, and prepare ourselves better to deal with any such occurrences in the future.
To this end, the Committee I established, under the leadership of the world-renowned Ghanaian scientist, Professor Kwabena Frimpong Boateng, to investigate Ghana’s potential as a vaccine manufacturing hub to meet national and regional needs, has presented its preliminary report which, amongst others, recommends the establishment of a National Vaccine Institute to spearhead this development.
Government has committed to inject seed funding of some twenty five million United States dollars (US$25 million) this year into this whole enterprise..”
The National Vaccine Institute to be established by the Government of Ghana is charged with delivering on the following mandates
1. Establishing local vaccine manufacturing plants;
2. Deepening Research & Development (R&D) for vaccines in Ghana;
3. Upgrading and strengthening the FDA;
4. Forging bilateral and multilateral partnerships for vaccine manufacturing in various areas, such as funding, clinical trials, technology transfer, licensing, and assignment of intellectual property rights;
5. Building the human resource base for vaccine discovery, development, and manufacture; and
6. Establishing a permanent national secretariat to coordinate vaccine development and manufacture.
SOURCE : CoverGhana.com.gh